BIOMAG-I Study OCT Analysis Confirmed That BIOTRONIK's Newest Resorbable Magnesium Scaffold Resorbed at 12 Months
First-in-Human Study Also Showed the Return of Vasomotion in Patients Treated with the DREAMS 3G Scaffold
Stay updated with breaking news from Michael Haude. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First-in-Human Study Also Showed the Return of Vasomotion in Patients Treated with the DREAMS 3G Scaffold
Germany: The one-year small BIOMAG-1 study results have shown that serial coronary imaging of patients with a resorbable magnesium scaffold (Biotronik's Dreams 3G) for coronary artery disease...
Serial OCT data presented this week at EAS 2023 suggest the vessel shows signs of stabilization, says Hector Garcia-Garcia.
Early results promising with DynamX bioadaptor, though traditional BRS hasn't been abandoned
R-One+ is a robotic solution that allows the interventional cardiologist to perform coronary angioplasties by controlling the devices using an integrated control command unit located in the cathlab or in the control room